Bookmarks (4) clear filters

Safe, effective, and available vaccines are the best long-term solution to the coronavirus pandemic.1 So it’s welcome news that two vaccines are poised for distribution and others will soon be on their way. Preliminary clinical trial data from these two vaccines, made by Pfizer and Moderna, indicate the vaccines are effective at stimulating a strong and long-lasting response against the virus responsible for COVID-19....

Scientists have now produced apparently effective vaccines at sufficient scale to vaccinate most vulnerable populations in the United States in the next few months, and the U.S. population more broadly in the next year. How can the distribution protect the masses without perpetuating inequalities? There are no simple answers but the way forward must be informed by understanding the complex interactions among the virus,...

Things have been different at the Tumwater Family Practice Clinic since COVID-19 came. Its patients in Washington state are being triaged over the phone, tested at the curbside, and treated by the doorstep. Many patients, afraid of contracting the disease, do not come in. Revenue for the private practice has plummeted almost 50 percent. When it came time for Jennifer Tyler, Tumwater’s clinic administrator,...

Last year, in late December, Li Wenliang, a young ophthalmologist, wrote 150 of his friends from medical circles. He said he had seen a number of cases of viral pneumonia come into the Wuhan Central Hospital, where he worked, and that they all seemed linked to the Huanan Seafood Market, the main source for restaurants in Wuhan, a metropolis of 11 million people, and...